Joel Greenblatt acquired 3.51 Thousand Apellis Pharmaceuticals shares worth $175 Thousand. That's 0.00% of their equity portfolio (1231st largest holding). The first Apellis Pharmaceuticals trade was made in Q3 2022. Since then Joel Greenblatt bought shares two more times and sold shares on three occasions. The investor's estimated purchase price is $178 Thousand, resulting in a loss of 1.6%.